Revisión NEJM sobre Covid + Enf Cardiovascular y tratamiento con IECA/ARAII https://t.co/kyuoy8pthh
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
@vpknerd @RinkeNOS @Wdekanter @Bongo__Fury @Bartissimus @NOS @OomenNL @EricTopol She regularly uses that 1 and seems to be the main source for the 2-3x higher risk of ICU. https://t.co/624Pu3xQya I also think smokers have an increased risk when they end u
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
@RinkeNOS @Wdekanter @vpknerd @Bongo__Fury @Bartissimus @NOS @OomenNL @EricTopol Ironical that @Wdekanter immediately makes the correlation causation error. The report she quotes clearly mentions that all they found were correlations and no causation may b
今日の早朝抄読会は「ACE-IやARBはCOVID-19を悪化させない」と言われる根拠となった論文。観察研究とはいえACE-IやスタチンはCOVID-19による病院死を減らしている。あらためて原著に当たることは大切。 https://t.co/5LNAtOQ1rn
RT @Wdekanter: RT Factors found to be independently associated with an increased risk of in-hospital death: age, COPD, smoking: #corona…
Ik ben zooooo blij dat ik ben gestopt in oktober 2018!
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/ZqfL4HIl3U
Lääkäreiden‡ Top-3, #2: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 3.5.2020, NEJM Lehden vaikuttavuus: 98. persentiili https://t.co/RbYdhSaBca 13/ https://t.co/wrzHUOZzDR
RT @Wdekanter: RT Factors found to be independently associated with an increased risk of in-hospital death: age, COPD, smoking: #corona…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/nbUvxwK7TM
COVID-19についてアジア、ヨーロッパ、北米の169病院の観察データベース。院内死亡リスクの増加因子は、65歳以上、冠動脈疾患、心不全、不整脈、COPD、喫煙。ACEi, ARBによる死亡リスク増加は認めず。 https://t.co/SFlFFSaZGG
Might be true, but the NEJM study indicates a higher mortality rate among current smokers (odds ratio, 1.79; 95% CI, 1.29-2.47) https://t.co/zOLkVlPiT1 Smoking or not, anecdotal protective effect vs death, make your choice.
@Alf_ArGzz https://t.co/1yj2VvNmSx faltó la hipertensión que, cómo se puede ver en la tabla del NEJM, es uno de los factores más serios. Por encima incluso de la diabetes.
RT @phil_w888: 13/ 1536 patients at 169 hospitals (121 in US, 48 in 10 other countries) "5.5% were current smokers" Smoking rates in all…
RT @f2harrell: Robust discussion of @NEJM #covid19 ACE paper https://t.co/ZD5YcpDFHf going on at https://t.co/4ohq1USQEC with discussion of…
@HameedAlSarraf رابط الدراسه كامله بالأسفل. I agree that several important variables like obesity was not shown, although I am sure that they did analysis for a lot of variables. They might be planning to publish the remaining data later https://t.co/Frd
.@ARanganathan72 sir Why don't we instead use ACE inhibitors to block the ACE2 receptor, which the SARS-CoV-2 already uses to gain entry into the cells? A study published by the NEJM has already confirmed that ACE inhibitors are not risk factors. https
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/t953zqajz9
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
RT @f2harrell: Robust discussion of @NEJM #covid19 ACE paper https://t.co/ZD5YcpDFHf going on at https://t.co/4ohq1USQEC with discussion of…
RT @f2harrell: Robust discussion of @NEJM #covid19 ACE paper https://t.co/ZD5YcpDFHf going on at https://t.co/4ohq1USQEC with discussion of…
(NEJM) Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/1HbYgZcMW2
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
Robust discussion of @NEJM #covid19 ACE paper https://t.co/ZD5YcpDFHf going on at https://t.co/4ohq1USQEC with discussion of @Lester_Domes Table II fallacy
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
- 2️⃣ Estas observaciones sugieren que cardiopatía isquémica, IC, arritmias o EPOC se relacionan con un ⬆️mortalidad intrahospitalaria en pts infectados. No🤷🏼♀️se observa ⬆️mortalidad hospitalaria en pacientes tratados con IECAs o ARA2. https://t.co/EJ0o
🔗https://t.co/EJ0oHZoO8x 1️⃣Nuevos datos publicados en @NEJM con casi 9.000 pts ingresados por infección por #coronavirus en Europa, Asia y América confirman que los pacientes con patología CV subyacente y aquellos tratados con determinados fármacos CVs po
RT @Kevin_Jackson: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19: https://t.co/o05UvtCiMI - We analyzed deidentified data…
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
RT @MateJankowski: Analiza opublikowana w NEJM uwzględniająca dane dotyczące 8910 przypadków COVID-19 wykazała, że #palenie tytoniu prawie…
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
Now the question remains, if there is any useful association of ACE inhibitors/ARBs with regards to #COVID19? @FefdeKaDoctor @Scorsesefangirl @dremtee
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
RT @Aiims1742: Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observatio…
Six weeks after the perspective below on RAAS inhibitors & #COVID19 was published, I think there is fairly strong observational data (2 in @NEJM, one in @TheLancet) to reiterate “Keep calm and ACEI on”. https://t.co/8lptuKEYDi https://t.co/IKnr6mNIND
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @Kevin_Jackson: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19: https://t.co/o05UvtCiMI - We analyzed deidentified data…
May 1 Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/tzsvTaFu8j https://t.co/V8I7TbNIuZ
RT @ajv67: @Lunera_Luz Después de ese estudio, se publicó este otro en @NEJM que mostró un aumento del 70% de riesgo de morir en fumadores…
Otro más de estudios sobre fumadores y riesgos al contraer covid-19. Noten q de estos, que son los reales, esos no los leen!
@Lunera_Luz Después de ese estudio, se publicó este otro en @NEJM que mostró un aumento del 70% de riesgo de morir en fumadores que sufren #COVIDー19 https://t.co/UaTHW84fSC
RT @Kevin_Jackson: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19: https://t.co/o05UvtCiMI - We analyzed deidentified data…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19: https://t.co/o05UvtCiMI - We analyzed deidentified data from the Surgical Outcomes Collaborative (Surgisphere), an international registry. Our analysis included data from… https://t.co/sPauod
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @Wdekanter: RT Factors found to be independently associated with an increased risk of in-hospital death: age, COPD, smoking: #corona…
Enfermedades cardiovasculares, farmacoterapia y mortalidad en Covid-19 https://t.co/O2FJALMjn1
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
Study confirms previous observations suggesting that underlying cardiovascular disease is associated with an increased risk of in-hospital death among patients hospitalized with #COVID19 https://t.co/v9LIcNdmVX | @NEJM
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @preeti_john: "A national group of healthcare leaders offers a guide to developing an action plan for #health systems to prepare for #co…
RT @preeti_john: "A national group of healthcare leaders offers a guide to developing an action plan for #health systems to prepare for #co…
RT @preeti_john: "A national group of healthcare leaders offers a guide to developing an action plan for #health systems to prepare for #co…
RT @preeti_john: "A national group of healthcare leaders offers a guide to developing an action plan for #health systems to prepare for #co…
@pinkvelvet21 look
"A national group of healthcare leaders offers a guide to developing an action plan for #health systems to prepare for #coronavirus pandemic." read Dr. SreyRam Kuy's publications in @NEJM & @nejmcatalyst - https://t.co/8HMC2ZdBBj & https://t.co/NGu
RT @accpchest: Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19: https://t.co/dRHCX5c20p via @NEJM #CHESTCritCare https://t.…
Cardiovascular Disease, Drug Therapy, and Mortality in #COVID19: https://t.co/dRHCX5c20p via @NEJM #CHESTCritCare https://t.co/kMkZ5Ji2WY
RT @zakkohane: Important clinical [research] question for #COVID19 from this @NEJM observational study https://t.co/gkAKRSWFIM Are impressi…
RT @DJHunter_EPI: Please just read the Discussion section and Editorial. Makes it clear these were published to reject the hypothesis that…
#medsm #internalmedicine @melissa_gon5 @LashNolen
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/cFnTAclPhy
RT @tabibito12: 心血管系合併症は死亡リスクあげるけれど、(当初懸念された)ACE阻害剤やARB(←血圧の薬)はそうでもなかった報告 Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 |…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/NbaOBr1YWm
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
Interesantemente, en este mismo estudio no se encontró que el uso de IECAs estuviera asociado a mayor mortalidad (Enlace https://t.co/fLjgY7SPSg)
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。 https://t.co/QRCGmFg…
RT @rincondesisifo: (NEJM) 3 estudios no encuentran daño asociado al uso de IECA o ARA2 en pac con #COVID19 https://t.co/iRJa5x9CPQ Est Obs…
RT @PolemicTMM: Statins reduce covid risks New England Journal of Medicine. 1st May. https://t.co/4hPRYYpUKm https://t.co/BpyNkMeDu2
RT @DrDavidKatz: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 - PubMed https://t.co/tMhawbcVZZ https://t.co/zJZZdclimd
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/ZpHUWNXnJI https://t.co/D7n7GhKT04 https://t.co/0gfAFqD224
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
RT @MateJankowski: Analiza opublikowana w NEJM uwzględniająca dane dotyczące 8910 przypadków COVID-19 wykazała, że #palenie tytoniu prawie…
RT @MateJankowski: Analiza opublikowana w NEJM uwzględniająca dane dotyczące 8910 przypadków COVID-19 wykazała, że #palenie tytoniu prawie…
@johnabachman 2/ a nice study that does look at the ace issue (not as a primary outcome) is Mehta et al at BWH who found some protection with ACE not ARB (https://t.co/ZxTxb0EF3L)
RT @jvalaball: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/j0Bv2sIrrb via @NEJM
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/j0Bv2sIrrb via @NEJM
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
“Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19” https://t.co/fYzKQ0rrhH https://t.co/zLTKT9L0WK
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 - PubMed https://t.co/tMhawbcVZZ https://t.co/zJZZdclimd
RT @meed_ref: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. https://t.co/pEc7YgqcJ3 -Included at COVID-19 & MEED CV DI…
RT @rincondesisifo: (NEJM) 3 estudios no encuentran daño asociado al uso de IECA o ARA2 en pac con #COVID19 https://t.co/iRJa5x9CPQ Est Obs…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/K64bxA09mZ
https://t.co/EcNtxLtulv 肺炎ウイルスっていうより、血管炎ウイルスって言った方が良かったり?
Los que quieran leer este artículo en extenso les dejo la liga : https://t.co/EaIbUXW5g7
#Fumar #mata... también en pacientes #COVID19 https://t.co/iObBYYlzsp (estudio observacional de factores asociados a mortalidad hospitalaria) https://t.co/Z6qGBwdYNm
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…